Law Offices of Sands White & Sands, PA   Attorneys
 
 
Auto Accidents
Medical Negligence
Prescription Drug Claims
Premises Liability
Product Liability
Nursing Home Negligence & Abuse
Insurance Company Disputes
Whistleblower Qui Tam Actions
White Collar Crime & Criminal Tax Defense

 

Fusarium Infection - Bausch & Lomb

Fusarium Infection/Bausch and Lomb

Bausch & Lomb first introduced ReNu with MoistureLoc® into the United States and several foreign markets, including Hong Kong and Singapore, in late 2004. In November of 2005, the Hong Kong Department of Health asked Bausch and Lomb to investigate a rising trend in keratitis among Hong Kong contact lens wearers. In February of 2006, the Singapore Department of Health identified ReNu as the common brand of lens solution of 21 of 22 Singapore patients with Fusarium keratitis. As a result, Bausch & Lomb withdrew ReNu with MoistureLoc® from the Hong Kong and Singapore markets, but took no action at that time to withdraw the product from the U.S. market.

On March 8th, The U.S. Centers for Disease Control received a report from an ophthalmologist in New Jersey regarding three patients with contact lens associated Fusarium keratitis. Initial contact by the CDC with several corneal disease specialty centers in the United States revealed that other centers also have seen recent increases in Fusarium keratitis. As of April 9th, a total of 109 patients with suspected Fusarium keratitis were under investigation in multiple states. According to the CDC, of the 30 patients interviewed at that time, 28 had worn contact lenses, and 26 could specifically recall using a contact lens solution manufactured by Bausch & Lomb.

On April 10th, the same day as the public release of the CDC data, Bausch & Lomb announced that it was suspending shipments of ReNu with MoistureLoc® to stores in the United States. On May 15th, Bausch & Lomb announced that it was permanently removing ReNu with MoistureLoc® from worldwide markets. In announcing the decision, Bausch & Lomb CEO Ronald L. Zarella acknowledged that “some aspect of the MoistureLoc formula may be increasing the relative risk of Fusarium infection in unusual circumstances.” According to subsequent statements by CEO Zarella, the company has determined that certain comfort- enhancing polymers unique to the ReNu with MoistureLoc® formula may actually have had the inadvertent effect of preventing the product’s fungal disinfectant from killing the Fusarium fungus. As of May 18th, the CDC had received reports of 130 confirmed cases of Fusarium keratitis since June 1, 2005, including 26 cases in Florida, more than any other State.

Sands White & Sands, P.A. is currently representing injured persons in fungal infection cases against Bausch & Lomb. If you are a contact lens wearer and have suffered an eye infection within the last two years that you know or suspect was fungal in nature, please call us immediately for further information about your legal rights.


MORE INFORMATION

USDA - Fusarium Infections

CDC - Fusarium Infections

Florida


Name:

Phone:

Email:

Question:

 

 


AV® Rated by Martindale-Hubbell*
The Highest Rating Available.

Martindale-Hubbell is the facilitator of a peer review rating process. Ratings reflect the confidential opinions of members of the Bar and Judiciary. Martindale-Hubbell Ratings fall into two categories - legal ability and general ethical standards. CV, BV and AV are registered certifications marks of Reed Elsevier PropertiesInc., used in accordance with the Martindale-Hubbell certification procedures, standards and policies.

[ Home ] [ Firm Overview ] [ Attorney Profiles ]
[ Practice Areas ] [ Locations ] [ Contact Us ]

 

Law Offices of Sands White & Sands, PA
Main Office:
760 White Street
Daytona Beach, Florida  32114
Phone: (386) 258-1622
Fax: (386) 238-3703
info@sandswhitesands.com

4875 Palm Coast Pkwy, NW, Suite 5
Palm Coast, Florida 32137